Hatóanyag |
Wada csoport |
Magyarországon forgalomban lévő készítmények |
α-methylfentanyl |
S7 |
|
α-methylthiofentanyl |
S7 |
|
α-pyrrolidinovalerophenone |
S6.b |
|
β-hydroxy-3-methylfentanyl |
S7 |
|
β-hydroxyfentanyl |
S7 |
|
Δ8-tetrahydrocannabinol |
S8 |
|
Δ9-tetrahydrocannabinol (THC, dronabinol) |
S8 |
|
(Iso)butyryl-F-fentanyl N-benzyl analogue |
S7 |
|
1,2-dimethylpentylamine (3-methylhexan-2-amine) |
S6.b |
|
1,3- dimethylbutylamine (4-methylpentan-2-amine) |
S6.b |
|
1,5-dimethylhexylamine (octodrine) |
S6.b |
|
1-androstene-3,17-dione |
S1.1 |
|
1-androstenediol (5α-androst-1-ene-3β, 17β-diol ) |
S1.1 |
|
1-androstenedione (5α-androst-1-ene-3,17-dione) |
S1.1 |
|
1-androsterone (3α-hydroxy-5α-androst-1-ene-17-one) |
S1.1 |
|
1-Epiandrosterone (3β-hydroxy-5α-androst-1-ene-17-one) |
S1.1 |
|
1-testosterone (17β-hydroxy-5α-androst-1-en-3-one; delta1-dihydro-testosterone) |
S1.1 |
|
17α-methyl [1,2,5]oxadiazolo[3',4':2,3]-5α-androstan-17β-ol (furazabol) |
S1.1 |
|
17α-methyl-5α-androst-2-en-17β-ol (desoxymethyltestosterone) |
S1.1 |
|
17β-hydroxy-17α-methyl-5α-androst-1-en-3-one (methyl-1-testosterone) |
S1.1 |
|
17β-hydroxy-17α-methylandrosta-1,4-dien-3-one (metandienone) |
S1.1 |
|
17β-hydroxy-17α-methylestr-4-en-3-one (methylnortestosterone) |
S1.1 |
|
17β-hydroxy-17α-methylestra-4,9,11-trien-3-one (methyltrienolone; metribolone) |
S1.1 |
|
17β-hydroxy-17α-methylestra-4,9-dien-3-one (methyldienolone) |
S1.1 |
|
17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one (methasterone) |
S1.1 |
|
17β-hydroxy-5α-androst-1-en-3-one (1-testosterone; delta1-dihydro-testosterone) |
S1.1 |
|
17β-hydroxy-5α-androstan-3-one (dihydrotestosterone; androstanolone; stanolone) |
S1.1 |
|
17β-hydroxyestr-4,9,11-trien-3-one (trenbolone) |
S1.1 |
|
17β-[(tetrahydropyran-2-yl)oxy]-1'H-pyrazolo[3,4:2,3]-5α-androstane (prostanozol) |
S1.1 |
|
17-hydroxy-18a-homo-19-nor-17α-pregna-4,9,11-trien-3-one (tetrahydrogestrinone; THG) |
S1.1 |
|
18α-homo-17b-hydroxyestr-4-en-3-one |
S1.1 |
|
19-norandrostenediol (estr-4-ene-3,17-diol) |
S1.1 |
|
19-norandrostenedione (estr-4-ene-3,17-dione) |
S1.1 |
|
19-norandrosterone |
S1.1 |
|
19-noretiocholanolone |
S1.1 |
|
19-norpregna-4-en-17α-ol (ethylestrenol) |
S1.1 |
|
19-nortestosterone (nandrolone; nortestosterone) |
S1.1 |
Retabolil ol. inj. |
2-(2-methyl-4-((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)methylthio)phenoxy) acetic acid; (GW1516; GW501516) |
S4 |
|
2-androstenol (5α-androst-2-en-17-ol) |
S4 |
|
2-androstenone (Delta-2; 5α-androst-2-en-17-one) |
S4 |
|
2-phenylpropan-1-amine (beta-methylphenethylamine) |
S6.b |
|
2-phenylpropan-1-amine (methylphenethylamine) |
S6.b |
|
3α-hydroxy-5α-androstan-17-one (androsterone) |
S1.1 |
|
3α-hydroxy-5ß-androstan-17-one (etiocholanolone; 5ß-androsterone) |
S1.1 |
|
3β-hydroxy-5α-androst-1-ene-17-one (1-Epiandrosterone) |
S1.1 |
|
3β-hydroxy-5α-androstan-17-one (epiandrosterone) |
S1.1 |
|
3β-hydroxyandrost-5-en-17-one (DHEA; prasterone; dehydroepiandrosteron) |
S1.1 |
|
3,17-keto-etiochol-triene |
S4 |
|
3-Androstenol (5α-androst-3-en-17-ol) |
S4 |
|
3-Androstenone (5α-androst-3-en-17-one) |
S4 |
|